Lo D - Search Results

1

The SPARCS: a novel assessment of contrast sensitivity and its reliability in patients with corrected refractive error.

Sun Y, Erdem E, Lyu A, Zangalli C, Wizov SS, Lo D, Spaeth EE, Richman J, Spaeth GL. Sun Y, et al. Among authors: lo d. Br J Ophthalmol. 2016 Oct;100(10):1421-6. doi: 10.1136/bjophthalmol-2015-307378. Epub 2016 Jan 12. Br J Ophthalmol. 2016. PMID: 26758536 Clinical Trial.

2

A clinical method to assess the effect of visual loss on the ability to perform activities of daily living.

Wei H, Sawchyn AK, Myers JS, Katz LJ, Moster MR, Wizov SS, Steele M, Lo D, Spaeth GL. Wei H, et al. Among authors: lo d. Br J Ophthalmol. 2012 May;96(5):735-41. doi: 10.1136/bjophthalmol-2011-300093. Epub 2012 Jan 12. Br J Ophthalmol. 2012. PMID: 22241927

3

Flicker defined form, standard perimetry and Heidelberg retinal tomography: Structure-function relationships.

Ichhpujani P, Lo DC, Cvintal V, Waisbourd M, Averbuch A, Leiby BE, Myers JS, Spaeth GL, Katz LJ. Ichhpujani P, et al. Can J Ophthalmol. 2015 Aug;50(4):290-6. doi: 10.1016/j.jcjo.2015.05.010. Can J Ophthalmol. 2015. PMID: 26257223

4

CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity.

Lemos MP, Fan L, Lo D, Laufer TM. Lemos MP, et al. Among authors: lo d. J Immunol. 2003 Nov 15;171(10):5077-84. doi: 10.4049/jimmunol.171.10.5077. J Immunol. 2003. PMID: 14607905

5

Islet endocrine cell MHC antigen expression in allograft rejection.

Markmann JF, Barker CF, Lo D, Brinster R, Tomaszewski J, Naji A. Markmann JF, et al. Among authors: lo d. Transplant Proc. 1990 Apr;22(2):847-8. Transplant Proc. 1990. PMID: 2109416 No abstract available.

6

Immunologic consequence of class II+ pancreatic islet allografts on recipient responsiveness.

Markmann JF, Barker CF, Lo D, Brinster R, Heber-Katz E, Naji A. Markmann JF, et al. Among authors: lo d. Transplant Proc. 1990 Aug;22(4):2052-3. Transplant Proc. 1990. PMID: 2143872 No abstract available.

7

Antigen presenting function of class II MHC expressing pancreatic beta cells.

Markmann J, Lo D, Naji A, Palmiter RD, Brinster RL, Heber-Katz E. Markmann J, et al. Among authors: lo d. Nature. 1988 Dec 1;336(6198):476-9. doi: 10.1038/336476a0. Nature. 1988. PMID: 3143077

8

Transgenic mice expressing MHC class II molecules with truncated A beta cytoplasmic domains reveal signaling-independent defects in antigen presentation.

Smiley ST, Laufer TM, Lo D, Glimcher LH, Grusby MJ. Smiley ST, et al. Among authors: lo d. Int Immunol. 1995 Apr;7(4):665-77. doi: 10.1093/intimm/7.4.665. Int Immunol. 1995. PMID: 7547694

9

A minimal level of MHC class II expression is sufficient to abrogate autoreactivity.

de Bont ES, Reilly CR, Lo D, Glimcher LH, Laufer TM. de Bont ES, et al. Among authors: lo d. Int Immunol. 1999 Aug;11(8):1295-306. doi: 10.1093/intimm/11.8.1295. Int Immunol. 1999. PMID: 10421787

10

Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis.

Fan L, Reilly CR, Luo Y, Dorf ME, Lo D. Fan L, et al. Among authors: lo d. J Immunol. 2000 Apr 15;164(8):3955-9. doi: 10.4049/jimmunol.164.8.3955. J Immunol. 2000. PMID: 10754285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

641 results

Search Page

Filters